| A mutation in histone H2B represents a new class of oncogenic driver RL Bennett, A Bele, EC Small, CM Will, B Nabet, JA Oyer, X Huang, ... Cancer discovery 9 (10), 1438-1451, 2019 | 70 | 2019 |
| A novel interaction of ecdysoneless (ECD) protein with R2TP complex component RUVBL1 is required for the functional role of ECD in cell cycle progression RA Mir, A Bele, S Mirza, S Srivastava, AA Olou, SA Ammons, JH Kim, ... Molecular and cellular biology 36 (6), 886-899, 2016 | 31 | 2016 |
| Overexpression of a novel cell cycle regulator ecdysoneless in breast cancer: a marker of poor prognosis in HER2/neu-overexpressing breast cancer patients X Zhao, S Mirza, A Alshareeda, Y Zhang, CB Gurumurthy, A Bele, JH Kim, ... Breast cancer research and treatment 134, 171-180, 2012 | 28 | 2012 |
| Cytoplasmic localization of alteration/deficiency in activation 3 (ADA3) predicts poor clinical outcome in breast cancer patients S Mirza, EA Rakha, A Alshareeda, S Mohibi, X Zhao, BJ Katafiasz, ... Breast cancer research and treatment 137, 721-731, 2013 | 23 | 2013 |
| Acetylation of mammalian ADA3 is required for its functional roles in histone acetylation and cell proliferation S Mohibi, S Srivastava, A Bele, S Mirza, H Band, V Band Molecular and cellular biology 36 (19), 2487-2502, 2016 | 16 | 2016 |
| The cell cycle regulator ecdysoneless cooperates with H-Ras to promote oncogenic transformation of human mammary epithelial cells A Bele, S Mirza, Y Zhang, R Ahmad Mir, S Lin, JH Kim, CB Gurumurthy, ... Cell cycle 14 (7), 990-1000, 2015 | 12 | 2015 |
| A mutation in histone H2B represents a new class of oncogenic driver. Cancer Discov. 2019; 9: 1438–1451. doi: 10.1158/2159-8290 RL Bennett, A Bele, EC Small, CM Will, B Nabet, JA Oyer, X Huang, ... CD-19-0393.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 12 | |
| Mammalian ECD protein is a novel negative regulator of the PERK arm of the unfolded protein response AA Olou, A Sarkar, A Bele, CB Gurumurthy, RA Mir, SA Ammons, S Mirza, ... Molecular and cellular biology, 2017 | 9 | 2017 |
| Breast cancer subtypes: two decades of journey from cell culture to patients X Zhao, CB Gurumurthy, G Malhotra, S Mirza, S Mohibi, A Bele, MG Quinn, ... Human Cell Transformation: Role of Stem Cells and the Microenvironment, 135-144, 2012 | 4 | 2012 |
| Ecdysoneless overexpression drives mammary tumorigenesis through upregulation of c-MYC and glucose metabolism BC Mohapatra, S Mirza, A Bele, CB Gurumurthy, M Raza, I Saleem, ... Molecular Cancer Research 20 (9), 1391-1404, 2022 | 1 | 2022 |
| Cells with DNMT3A Mutations Are More Sensitive to Cytarabine-Induced DNA Damage K Venugopal, J Li, DE Shabashvili, LM Posada, Y Feng, D Dupere-Richer, ... Blood 132, 2643, 2018 | | 2018 |
| Role of ecdysoneless protein in the regulation of cell cycle progression and breast oncogenesis AR Bele University of Nebraska Medical Center, 2015 | | 2015 |
| Synergistic function of a novel cell cycle regulator, Ecdysoneless with oncogenic Ras in the regulation of cell cycle and transformation A Bele, S Mirza, R Mir, S Mohibi, H Band, V Band Cancer Research 74 (19_Supplement), 1306-1306, 2014 | | 2014 |
| Ada3, a component of STAGA HAT complex, controls cell cycle by regulating c-myc S Mohibi, C Gurumurthy, S Mirza, A Nag, B Katafiasz, A Bele, M Naramura, ... Cancer Research 72 (8_Supplement), 3062-3062, 2012 | | 2012 |
| Expression of Ecdysoneless in breast cancer progression predicts poor outcome in breast cancer patients S Mirza, X Zhao, A Alshareeda, Y Zhang, CB Gurumurthy, A Bele, JH Kim, ... Cancer Research 72 (8_Supplement), 4593-4593, 2012 | | 2012 |
| Synergistic role of ecdysoneless with oncogenic Ras in transformation of human mammary epithelial cells A Bele, CB Gurumurthy, X Zhao, J Wang, S Mirza, S Mohibi, H Band, ... Cancer Research 72 (8_Supplement), 4177-4177, 2012 | | 2012 |
| ADA3, a component of ATAC complex regulates DNA damage response S Mirza, S Mohibi, CB Gurumurthy, BJJ Katafiasz, X Zhao, A Bele, H Band, ... Cancer Research 71 (8_Supplement), 3929-3929, 2011 | | 2011 |
